Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. - Wikidata - wikimedia - TriplyDB

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

http://www.wikidata.org/entity/Q43608796

about

Pneumococcal vaccination during pregnancy for preventing infant infection Transformative Innovations in Reproductive, Maternal, Newborn, and Child Health over the Next 20 Years.Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness Pneumococcal vaccine and patients with pulmonary diseases What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly Pneumococcal Capsules and Their Types: Past, Present, and Future Population-based epidemiology and microbiology of community-onset bloodstream infections Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli.Pneumococcal vaccination of older adults: conjugate or polysaccharide?Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement Macrolide Resistance in Streptococcus pneumoniae Streptococcus pneumoniae carriage in the Gaza strip Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China The anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventions Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee.Estimating the population-level impact of vaccines using synthetic controls.Contribution of vaccines to our understanding of pneumococcal disease.Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia.Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States Using pneumococcal carriage data to monitor postvaccination changes in invasive disease.Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.How I manage Evans Syndrome and AIHA cases in children.Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing.Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015-2016.Pneumococcal Vaccination Strategies. An Update and Perspective.Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 - 2015 Genetic diversity of Streptococcus pneumoniae causing meningitis and sepsis in Singapore during the first year of PCV7 implementation

P2860

Q24186525-582A67E8-5D44-4975-89EB-80AB3290EB75 Q26765049-98E47EEB-42E9-4F4C-84EF-7055803CE4A4 Q26770693-0AF75A84-7A5C-4525-8EB5-F69616ED9916 Q26825944-D2ABC63A-C69E-49E7-A7F7-6C32E601CA4C Q26852219-15169ED4-2EC4-4D56-80CE-FF8151DFABB0 Q26865184-7B81F1D8-57BD-4E12-AE1B-6B2455104B1E Q26999313-263C6B1A-5EE4-47D2-9591-EB2A10D0D938 Q27006887-8A986C2D-D3D2-4727-ADFB-9DF74F6FFE82 Q27013639-874D9B95-8A1B-49CA-8AF4-3D0227C35F83 Q27336832-8E5321F4-D7EC-4B37-BC52-D453433C93A1 Q27690289-3BD8974A-6B01-41AA-A177-957A73FC0D43 Q28069508-160CA57B-6357-4509-9248-A626FFE93B29 Q28070243-4FADBEAA-BDAF-4C8C-BCC3-B6DAE9AAAB43 Q28482482-88851CB7-47A3-48AB-BB8C-B93D85F16B2D Q28550988-22D298CD-C327-4D56-BFC4-2F45F8446586 Q28732491-6FDC4EE3-5DAC-46F9-A021-814CC486C43E Q28742681-E97CC327-2576-44C3-9366-F8FB953A6460 Q28743870-B574BEBD-6A41-4661-8F1D-F73FFA1A2522 Q30251593-706BD5BF-52CF-4BA8-9722-FA8A93C709A1 Q30274913-B843AAD3-4535-4D06-8A35-0C78C70AA1E3 Q30398164-6BB1FD84-B5A6-43E4-8BE4-DB0245CB2218 Q30406750-31E30F0B-3D8A-4ACA-B07A-3F538B78D066 Q30410509-7CD581F0-19D2-456A-AA70-C96737322290 Q30412578-93D721DB-C78D-4468-8A50-4188301D46C4 Q30425723-25D24C15-CD09-4E93-9D42-CA0D4FE256B4 Q30430741-FC853275-E03A-48CF-B3F0-31F62CAE3539 Q30665494-4CB54592-4D64-4C82-B5D9-18B61320D256 Q31063000-D1DAE750-5F30-4CC5-A057-279753708EF5 Q33428041-19BBB9FF-629B-4507-B454-1DF83C2EE1C1 Q33594345-EAA0AE56-8BA8-44B9-BDE9-DC6D35EECB70 Q33653107-2165F360-B785-4156-B8C0-54268CC3CABB Q33675229-551553C3-E744-4AB1-93E8-AF2E3FEE4200 Q33706645-8D3D91E9-4525-4D58-8247-67722801BA1C Q33713198-9E79E06E-C68E-480F-8CB9-6AD3D2276F0F Q33721628-12589B09-1903-4662-9E36-075E287330FE Q33724635-5EF81F6C-2A21-4C30-8BCA-44FE05DC7251 Q33772409-DA709905-F280-41F2-8281-9C4B8B24E67B Q33776584-40D6EB9F-36C3-40E4-8068-EC7776DF951C Q33788115-DFA91601-0E1B-4D2D-BBC7-12C74D5ED1E5 Q33834915-BB6A542C-9C43-425D-A6C0-4673E8CE9E51

P2860

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

http://www.wikidata.org/entity/Q43608796

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@en

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@nl

type

label

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@en

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@nl

prefLabel

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@en

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@nl

P1433

Q43608796-06E22936-6E0C-43F0-B57B-6C94C597C27A

P1476

Q43608796-B79EF478-92DB-48D2-B39B-A0FF3E550A53

P2093

Q43608796-13385413-DABF-4F11-BFE1-7A3A9AF3DE45

Q43608796-2728BBDF-C653-4507-A4AA-4EC7221103C2

Q43608796-2BA4D0B1-731A-4A13-B7C4-8E284A9F8A2E

Q43608796-2CA7A551-A07C-422D-9B7A-DB8AA3DC22F3

Q43608796-7A63A9F9-2B66-4A8B-A513-7653F9672D8C

Q43608796-87ED74FA-1006-4915-9371-2F3F9C93144B

Q43608796-8F870253-3B55-4F08-AF44-8D7AC10B68FF

Q43608796-90F5BEBB-A83C-4966-9FEA-D84238DAD348

Q43608796-AACA014C-3A4C-4B7B-8E81-A339471FD93D

Q43608796-AC94F0F8-B01C-4266-B28D-38F99217C6CA

P304

Q43608796-FF93D20D-06C8-4DBC-88F2-D91848AFBD16

P31

Q43608796-E96F574F-BB1D-43FB-BF77-2CC025EDC196

P356

Q43608796-A8B8A140-55C2-4A0B-852E-57C68A92F69E

P407

Q43608796-F89B04F9-E8C2-4002-B297-2C686B1DC2F3

P433

Q43608796-D0E12347-086E-4518-94D8-DE6300AAEF6A

P478

Q43608796-3288C81C-D685-4996-8BD3-41025937A1C0

P50

Q43608796-4F61578E-BF72-45EA-B777-3AF85E037784

P577

Q43608796-39AA20CC-6E84-4A29-9D46-0F52BFEB7BB5

P5875

Q43608796-86E3BBC7-0A80-4622-8728-E708573D4481

P698

Q43608796-B9D3E824-35B8-4BA2-9CFE-D7AA08014B22

P356

P1433

The Journal of Infectious Diseases

P1476

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

@en

P2093

Active Bacterial Core Surveillance/Emerging Infections Program Network

http://www.w3.org/2001/XMLSchema#string

Allen S Craig

http://www.w3.org/2001/XMLSchema#string

Ann Thomas

http://www.w3.org/2001/XMLSchema#string

Arthur Reingold

http://www.w3.org/2001/XMLSchema#string

Bernard W Beall

http://www.w3.org/2001/XMLSchema#string

Catherine Lexau

http://www.w3.org/2001/XMLSchema#string

Cynthia G Whitney

http://www.w3.org/2001/XMLSchema#string

James Hadler

http://www.w3.org/2001/XMLSchema#string

Lee H Harrison

http://www.w3.org/2001/XMLSchema#string

Matthew R Moore

http://www.w3.org/2001/XMLSchema#string

P304

32-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/648593

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

William Schaffner

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40041017

http://www.w3.org/2001/XMLSchema#string

P698

19947881

http://www.w3.org/2001/XMLSchema#string